FAP and lung cancer: First, the absence of suitable preclinical models, including those for FAP+αSMA+ and MYH11+αSMA+ CAFs and immunotherapy-sensitive lung cancer with mTLSs, hindered our ability to conduct functional experiments to definitively establish a causal relationship between these specific CAF subsets, T cell exhaustion markers, and Treg infiltration.